Factor VIII safety: plasma-derived versus recombinant products. - Wikidata - wikimedia - TriplyDB

Factor VIII safety: plasma-derived versus recombinant products.

Factor VIII safety: plasma-derived versus recombinant products.

http://www.wikidata.org/entity/Q37882787

about

Present and future challenges in the treatment of haemophilia: the patient's perspective Uncovered needs in the management of inherited bleeding disorders in Italy.Issues in pediatric haemophilia care Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.The demand for factor VIII and for factor IX and the toll fractionation product surplus management.A Single Center Analysis of the Positivity of Hepatitis B Antibody after Neonatal Vaccination Program in Korea.The modern treatment of haemophilia: a narrative review Clinical and organisational aspects of haemophilia care: the patients' view.Factor VIII inhibitor and source of replacement therapy.Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A.

P2860

Q27022801-00D137D5-1D89-4184-973F-FE95C807D3EB Q33708980-C23A7684-EBB3-424F-81E4-67FE1EFC9D4D Q36835166-36A253E3-282D-48D1-B8C9-E0E724827C87 Q37370343-83C110CB-9ED9-4158-BC07-D5FB064D738C Q37370352-4293672B-9148-455B-9917-0CE3B59AF31E Q37740476-391186E1-3C82-4CD6-A74D-673DE79B76F6 Q38025882-6E75DBB7-A4D8-4260-8AB4-93004A094681 Q43056244-5045309E-7DBB-470D-A241-42F0D73A733E Q43056247-A6527425-7C26-4749-BA9E-8F87A19F1823 Q45875675-B77A5337-6242-4EEB-8FE7-2660C15B80BD

P2860

Factor VIII safety: plasma-derived versus recombinant products.

http://www.wikidata.org/entity/Q37882787

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Factor VIII safety: plasma-derived versus recombinant products.

@en

Factor VIII safety: plasma-derived versus recombinant products.

@nl

type

label

Factor VIII safety: plasma-derived versus recombinant products.

@en

Factor VIII safety: plasma-derived versus recombinant products.

@nl

prefLabel

Factor VIII safety: plasma-derived versus recombinant products.

@en

Factor VIII safety: plasma-derived versus recombinant products.

@nl

P1433

Q37882787-177E7865-885C-4EFA-B89D-6442530981FB

P1476

Q37882787-87679A53-AF35-47B3-A6F8-839D62B6BA9B

P2093

Q37882787-ED400BE1-B525-46BC-90E9-46C35339536C

P2860

Q37882787-056384A1-7772-4083-98F5-05489FC73B71

Q37882787-0662DE86-B451-42C2-AC75-CAD1AFB71D32

Q37882787-1D2F5B3A-DAF8-4436-AE8B-B9E048F0E58B

Q37882787-1F325833-B6FB-4EC6-9557-FD5483D5D89D

Q37882787-208F31AE-0985-4AF4-9CF0-44B17CB9C7EF

Q37882787-20E04EE7-4452-451E-A2C4-A93B185E1C04

Q37882787-264DA470-C1AC-4A52-8E61-5CB9B0E3E25A

Q37882787-2687A753-2664-43F9-826E-A202681FC2D2

Q37882787-2D1C5D04-72DC-43CB-90E3-590DFB52E8DF

Q37882787-2DABB45A-D869-411A-80B9-C6EC465F8935

P304

Q37882787-3BAC994E-5A3A-486B-B8CD-B0CE4CF65EF3

P31

Q37882787-4884362D-CA6B-467A-BBAB-92A97EFCE30F

P356

Q37882787-E0E83FFE-741E-46E0-9B33-38BA7157F571

P433

Q37882787-3B28FC7B-0AF3-438D-AE2A-6CA8EC291A48

P478

Q37882787-021DA200-6D48-4600-A588-A215F4E787E0

P577

Q37882787-CFC92A9E-D0BA-4B8D-B3EC-9FD04F654E64

P5875

Q37882787-8044EF7A-DA1E-4BE3-A585-5BC47B456964

P698

Q37882787-2ECD920D-0AE2-4209-99BA-85F0F2910A29

P932

Q37882787-5C48DE4A-A587-477C-B228-1DF3143D404D

P356

P1433

Blood transfusion = Trasfusione del sangue

P1476

Factor VIII safety: plasma-derived versus recombinant products.

@en

P2093

Alessandro Gringeri

http://www.w3.org/2001/XMLSchema#string

P2860

Use of recombinant antihemophilic factor in the treatment of two patients with classic hemophilia

Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS

Molecular cloning of a cDNA encoding human antihaemophilic factor

Pneumocystis carinii pneumonia among persons with hemophilia A

Structure of human factor VIII

The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1.

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency.

Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.

The role of plasma-derived factor VIII/von Willebrand factor concentrates in the treatment of hemophilia A patients.

P304

366-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2450/2011.0092-10

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51179767

http://www.w3.org/2001/XMLSchema#string

P698

21627925

http://www.w3.org/2001/XMLSchema#string

P932

3200403

http://www.w3.org/2001/XMLSchema#string